These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8340384

  • 1. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell.
    Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K, Sugino H.
    J Biol Chem; 1993 Jul 25; 268(21):15579-87. PubMed ID: 8340384
    [Abstract] [Full Text] [Related]

  • 2. Follistatin and its role as an activin-binding protein.
    Sugino H, Sugino K, Hashimoto O, Shoji H, Nakamura T.
    J Med Invest; 1997 Aug 25; 44(1-2):1-14. PubMed ID: 9395712
    [Abstract] [Full Text] [Related]

  • 3. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells.
    Nakamura T, Sugino K, Titani K, Sugino H.
    J Biol Chem; 1991 Oct 15; 266(29):19432-7. PubMed ID: 1918055
    [Abstract] [Full Text] [Related]

  • 4. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate.
    Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H.
    J Biol Chem; 1997 May 23; 272(21):13835-42. PubMed ID: 9153241
    [Abstract] [Full Text] [Related]

  • 5. Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin.
    Inouye S, Guo Y, DePaolo L, Shimonaka M, Ling N, Shimasaki S.
    Endocrinology; 1991 Aug 23; 129(2):815-22. PubMed ID: 1906804
    [Abstract] [Full Text] [Related]

  • 6. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.
    de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJ.
    Mol Cell Endocrinol; 1996 Jan 15; 116(1):105-14. PubMed ID: 8822271
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin.
    Yamane Y, Tohno-oka R, Yamada S, Furuya S, Shiokawa K, Hirabayashi Y, Sugino H, Sugahara K.
    J Biol Chem; 1998 Mar 27; 273(13):7375-81. PubMed ID: 9516434
    [Abstract] [Full Text] [Related]

  • 8. Production of activin-binding protein by rat granulosa cells in vitro.
    Saito S, Nakamura T, Titani K, Sugino H.
    Biochem Biophys Res Commun; 1991 Apr 15; 176(1):413-22. PubMed ID: 1902106
    [Abstract] [Full Text] [Related]

  • 9. Isolation and characterization of Xenopus follistatin and activins.
    Fukui A, Nakamura T, Sugino K, Takio K, Uchiyama H, Asashima M, Sugino H.
    Dev Biol; 1993 Sep 15; 159(1):131-9. PubMed ID: 8365557
    [Abstract] [Full Text] [Related]

  • 10. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL.
    Endocrinology; 2002 May 15; 143(5):1613-24. PubMed ID: 11956142
    [Abstract] [Full Text] [Related]

  • 11. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.
    Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF.
    Endocrinology; 1996 Jan 15; 137(1):240-7. PubMed ID: 8536619
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of native activin B.
    Nakamura T, Asashima M, Eto Y, Takio K, Uchiyama H, Moriya N, Ariizumi T, Yashiro T, Sugino K, Titani K.
    J Biol Chem; 1992 Aug 15; 267(23):16385-9. PubMed ID: 1644823
    [Abstract] [Full Text] [Related]

  • 13. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL.
    Endocrinology; 1996 Feb 15; 137(2):486-94. PubMed ID: 8593793
    [Abstract] [Full Text] [Related]

  • 14. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells.
    Hosseini G, Liu J, de Agostini AI.
    J Biol Chem; 1996 Sep 06; 271(36):22090-9. PubMed ID: 8703018
    [Abstract] [Full Text] [Related]

  • 15. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
    Bilezikjian LM, Corrigan AZ, Vaughan JM, Vale WM.
    Endocrinology; 1993 Dec 06; 133(6):2554-60. PubMed ID: 8243277
    [Abstract] [Full Text] [Related]

  • 16. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin.
    Hashimoto O, Kawasaki N, Tsuchida K, Shimasaki S, Hayakawa T, Sugino H.
    Cell Signal; 2000 Aug 06; 12(8):565-71. PubMed ID: 11027950
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the activin-binding protein follistatin cultured human luteinizing granulosa cells: characterization of the effects of follicle stimulating hormone, prostaglandin E2, and different growth factors.
    Tuuri T, Ritvos O.
    Biol Reprod; 1995 Dec 06; 53(6):1508-16. PubMed ID: 8562709
    [Abstract] [Full Text] [Related]

  • 18. Follistatin: essential role for the N-terminal domain in activin binding and neutralization.
    Sidis Y, Schneyer AL, Sluss PM, Johnson LN, Keutmann HT.
    J Biol Chem; 2001 May 25; 276(21):17718-26. PubMed ID: 11279126
    [Abstract] [Full Text] [Related]

  • 19. Activin-binding protein is present in pituitary.
    Kogawa K, Nakamura T, Sugino K, Takio K, Titani K, Sugino H.
    Endocrinology; 1991 Mar 25; 128(3):1434-40. PubMed ID: 1900230
    [Abstract] [Full Text] [Related]

  • 20. Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins.
    Wang Q, Keutmann HT, Schneyer AL, Sluss PM.
    Endocrinology; 2000 Sep 25; 141(9):3183-93. PubMed ID: 10965889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.